|
1
|
Schwartz AG and Cote ML: Epidemiology of
lung cancer. Adv Exp Med Biol. 893:21–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sher T, Dy GK and Adjei AA: Small cell
lung cancer. Mayo Clin Proc. 83:355–367. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuribayashi K, Funaguchi N and Nakano T:
Chemotherapy for advanced non-small cell lung cancer with a focus
on squamous cell carcinoma. J Cancer Res Ther. 12:528–534. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Zhao Y, Li C, Zhu L, Liu C and Liu
L: The revision of 8th edition TNM stage criteria is more accurate
in prediction postoperative survival for SCLC patients. Int J Surg.
48:83–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Cancer Society: Cancer facts and
figures 2015. American Cancer Society; Atlanta, GA; 2015,
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2015/cancer-facts-and-figures-2015.pdf
|
|
6
|
Loomis D, Grosse Y, Lauby-Secretan B, El
Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock
H and Straif K; International Agency for Research on Cancer
Monograph Working Group IARC: The carcinogenicity of outdoor air
pollution. Lancet Oncol. 14:1262–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kenfield SA, Wei EK, Stampfer MJ, Rosner
BA and Colditz GA: Comparison of aspects of smoking among the four
histological types of lung cancer. Tob Control. 17:198–204. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muscat JE, Stellman SD, Zhang ZF, Neugut
AI and Wynder EL: Cigarette smoking and large cell carcinoma of the
lung. Cancer Epidemiol Biomarkers Prev. 6:477–480. 1997.PubMed/NCBI
|
|
10
|
Couraud S, Zalcman G, Milleron B, Morin F
and Souquet PJ: Lung cancer in never smokers-a review. Eur J
Cancer. 48:1299–1311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schaal C and Chellappan S:
Nicotine-mediated regulation of nicotinic acetylcholine receptors
in non-small cell lung adenocarcinoma by E2F1 and STAT1
transcription factors. PLoS One. 11:e0156452016. View Article : Google Scholar
|
|
12
|
Cardinale A, Nastrucci C, Cesario A and
Russo P: Nicotine: Specific role in angiogenesis, proliferation and
apoptosis. Crit Rev Toxicol. 42:68–89. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dasgupta P, Rizwani W, Pillai S, Kinkade
R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, et
al: Nicotine induces cell proliferation, invasion and
epithelial-mesenchymal transition in a variety of human cancer cell
lines. Int J Cancer. 124:36–45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Improgo MR, Scofield MD, Tapper AR and
Gardner PD: The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene
cluster: Dual role in nicotine addiction and lung cancer. Prog
Neurobiol. 92:212–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sargent PB: The diversity of neuronal
nicotinic acetylcholine receptors. Annu Rev Neurosci. 16:403–443.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lukas RJ, Changeux JP, Le Novère N,
Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA,
Clarke PB, Collins AC, et al: International Union of Pharmacology.
XX. Current status of the nomenclature for nicotinic acetylcholine
receptors and their subunits. Pharmacol Rev. 51:397–401.
1999.PubMed/NCBI
|
|
18
|
Dani JA and Bertrand D: Nicotinic
acetylcholine receptors and nicotinic cholinergic mechanisms of the
central nervous system. Annu Rev Pharmacol Toxico. 47:699–729.
2007. View Article : Google Scholar
|
|
19
|
Papke RL, Bagdas D, Kulkarni AR, Gould T,
AlSharari SD, Thakur GA and Damaj MI: The analgesic-like properties
of the alpha7 nAChR silent agonist NS6740 is associated with
non-conducting conformations of the receptor. Neuropharmacology.
91:34–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arias HR, Richards VE, Ng D, Ghafoori ME,
Le V and Mousa SA: Role of non-neuronal nicotinic acetylcholine
receptors in angiogenesis. Int J Biochem Cell Biol. 41:1441–1451.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Russo P and Taly A: α7-Nicotinic
acetylcholine receptors: An old actor for new different roles. Curr
Drug Targets. 13:574–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Egleton RD, Brown KC and Dasgupta P:
Nicotinic acetylcholine receptors in cancer: Multiple roles in
proliferation and inhibition of apoptosis. Trends Pharmacol Sci.
29:151–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Y, Ritzenthaler JD, Roman J and Han
S: Nicotine stimulates human lung cancer cell growth by inducing
fibronectin expression. Am J Respir Cell Mol Biol. 37:681–690.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schuller HM: Regulatory role of the
α7nAChR in cancer. Curr Drug Targets. 13:680–687. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singh S, Pillai S and Chellappan S:
Nicotinic acetylcholine receptor signaling in tumor growth and
metastasis. J Oncol. 2011:4567432011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pillai S and Chellappan S: α7 nicotinic
acetylcholine receptor subunit in angiogenesis and epithelial to
mesenchymal transition. Curr Drug Targets. 13:671–679. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang C, Ding XP, Zhao QN, Yang XJ, An SM,
Wang H, Xu L, Zhu L and Chen HZ: Role of α7-nicotinic acetylcholine
receptor in nicotine-induced invasion and epithelial-to-mesenchymal
transition in human non-small cell lung cancer cells. Oncotarget.
7:59199–59208. 2016.PubMed/NCBI
|
|
28
|
Seifert U, Schlanstedt-Jahn U and Klug SJ:
Screening for cancer. Internist (Berl). 56:1114–1123. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
National Cancer Institute: SEER cancer
statistics review, 1975–2011. https://seer.cancer.gov/archive/csr/1975_2011/Updated
December 17. 2014
|
|
34
|
Warren GW and Cummings KM: Tobacco and
lung cancer: Risks, trends, and outcomes in patients with cancer.
Am Soc Clin Oncol Educ Book:. pp. 359–364. 2013, View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hecht SS: Tobacco carcinogens, their
biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3:733–744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Whitrow MJ, Smith BJ, Pilotto LS,
Pisaniello D and Nitschke M: Environmental exposure to carcinogens
causing lung cancer: Epidemiological evidence from the medical
literature. Respirology. 8:513–521. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
National Center for Chronic Disease
Prevention and Health Promotion (US) Office on Smoking and Health:
The health consequences of smoking-50 years of progress: A report
of the surgeon general. Centers for Disease Control and Prevention
(US). Atlanta, GA; 2014
|
|
38
|
Jha P: Avoidable global cancer deaths and
total deaths from smoking. Nat Rev Cancer. 9:655–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wessler I and Kirkpatrick CJ:
Acetylcholine beyond neurons: The non-neuronal cholinergic system
in humans. Br J Pharmacol. 154:1558–1571. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cattaneo MG, D'Atri F and Vicentini LM:
Mechanisms of mitogen-activated protein kinase activation by
nicotine in small-cell lung carcinoma cells. Biochem J.
328:499–503. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song P, Sekhon HS, Proskocil B, Blusztajn
JK, Mark GP and Spindel ER: Synthesis of acetylcholine by lung
cancer. Life Sci. 72:2159–2168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song P, Sekhon HS, Lu A, Arredondo J,
Sauer D, Gravett C, Mark GP, Grando SA and Spindel ER: M3
muscarinic receptor antagonists inhibit small cell lung carcinoma
growth and mitogen-activated protein kinase phosphorylation induced
by acetylcholine secretion. Cancer Res. 67:3936–3944. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zou W and Chen L: Inhibitory B7-family
molecules in the tumour microenvironment. Nat Rev Immunol.
8:467–477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Song P, Sekhon HS, Fu XW, Maier M, Jia Y,
Duan J, Proskosil BJ, Gravett C, Lindstrom J, Mark GP, et al:
Activated cholinergic signaling provides a target in squamous cell
lung carcinoma. Cancer Res. 68:4693–4700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Song P, Sekhon HS, Jia Y, Keller JA,
Blusztajn JK, Mark GP and Spindel ER: Acetylcholine is synthesized
by and acts as an autocrine growth factor for small cell lung
carcinoma. Cancer Res. 63:214–221. 2003.PubMed/NCBI
|
|
46
|
Dasgupta P, Kinkade R, Joshi B, Decook C,
Haura E and Chellappan S: Nicotine inhibits apoptosis induced by
chemotherapeutic drugs by up-regulating XIAP and survivin. Proc
Natl Acad Sci USA. 103:6332–6337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dasgupta P, Rastogi S, Pillai S,
Ordonez-Ercan D, Morris M, Haura E and Chellappan S: Nicotine
induces cell proliferation by beta-arrestin-mediated activation of
Src and Rb-Raf-1 pathways. J Clin Invest. 16:2208–2217. 2006.
View Article : Google Scholar
|
|
48
|
Lam DC, Girard L, Ramirez R, Chau WS, Suen
WS, Sheridan S, Tin VP, Chung LP, Wong MP, Shay JW, et al:
Expression of nicotinic acetylcholine receptor subunit genes in
non-small-cell lung cancer reveals differences between smokers and
nonsmokers. Cancer Res. 67:4638–4647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Brown KC, Perry HE, Lau JK, Jones DV,
Pulliam JF, Thornhill BA, Crabtree CM, Luo H, Chen YC and Dasgupta
P: Nicotine induces the up-regulation of the α7-nicotinic receptor
(α7-nAChR) in human squamous cell lung cancer cells via the
Sp1/GATA protein pathway. J Biol Chem. 288:33049–33059. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bordas A, Cedillo JL, Arnalich F
Esteban-Rodriguez I, Guerra-Pastrián L, de Castro J, Martín-Sánchez
C, Atienza G, Fernández-Capitan C, Rios JJ and Montiel C:
Expression patterns for nicotinic acetylcholine receptor subunit
genes in smoking-related lung cancers. Oncotarget. 8:67878–67890.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Paleari L, Catassi A, Ciarlo M, Cavalieri
Z, Bruzzo C, Servent D, Cesario A, Chessa L, Cilli M, Piccardi F,
et al: Role of alpha7-nicotinic acetylcholine receptor in human
non-small cell lung cancer proliferation. Cell Prolif. 41:936–959.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Davis R, Rizwani W, Banerjee S, Kovacs M,
Haura E, Coppola D and Chellappan S: Nicotine promotes tumor growth
and metastasis in mouse models of lung cancer. PLoS One.
4:e75242009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Medjber K, Freidja ML, Grelet S, Lorenzato
M, Maouche K, Nawrocki-Raby B, Birembaut P, Polette M and Tournier
JM: Role of nicotinic acetylcholine receptors in cell proliferation
and tumour invasion in broncho-pulmonary carcinomas. Lung Cancer.
87:258–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Al-Wadei HA, Al-Wadei MH and Schuller HM:
Cooperative regulation of non-small cell lung carcinoma by
nicotinic and beta-adrenergic receptors: A novel target for
intervention. PLoS One. 7:e299152012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zovko A, Viktorsson K, Lewensohn R, Kološa
K, Filipič M, Xing H, Kem WR, Paleari L and Turk T: APS8, a
polymeric alkylpyridinium salt blocks α7 nAChR and induces
apoptosis in non-small cell lung carcinoma. Mar Drugs.
11:2574–2594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Paleari L, Sessa F, Catassi A, Servent D,
Mourier G, Doria-Miglietta G, Ognio E, Cilli M, Dominioni L,
Paolucci M, et al: Inhibition of non-neuronal alpha7-nicotinic
receptor reduces tumorigenicity in A549 NSCLC xenografts. Int J
Cancer. 125:199–211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Grozio A, Paleari L, Catassi A, Servent D,
Cilli M, Piccardi F, Paganuzzi M, Cesario A, Granone P, Mourier G
and Russo P: Natural agents targeting the alpha7-nicotinic-receptor
in NSCLC: A promising prospective in anti-cancer drug development.
Int J Cancer. 122:1911–1915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sheppard BJ, Williams M, Plummer HK and
Schuller HM: Activation of voltage-operated Ca2+-channels in human
small cell lung carcinoma by the tobacco-specific nitrosamine
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Int J Oncol.
16:513–518. 2000.PubMed/NCBI
|
|
59
|
Jull BA, Plummer HK III and Schuller HM:
Nicotinic receptor-mediated activation by the tobacco-specific
nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in
phosphorylation of c-myc in human small cell lung carcinoma cells
and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol.
127:707–717. 2001.PubMed/NCBI
|
|
60
|
Hung YH and Hung WC:
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances
invasiveness of lung cancer cells by up-regulating contactin-1 via
the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway.
Chem Biol Interact. 179:154–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhong X, Fan Y, Ritzenthaler JD, Zhang W,
Wang K, Zhou Q and Roman J: Novel link between prostaglandin E2
(PGE2) and cholinergic signaling in lung cancer: The role of c-Jun
in PGE2-induced α7 nicotinic acetylcholine receptor expression and
tumor cell proliferation. Thorac Cancer. 6:488–500. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sun X, Ritzenthaler JD, Zhong X, Zheng Y,
Roman J and Han S: Nicotine stimulates PPARbeta/delta expression in
human lung carcinoma cells through activation of PI3K/mTOR and
suppression of AP-2alpha. Cancer Res. 69:6445–6453. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chernyavsky AI, Shchepotin IB and Grando
SA: Mechanisms of growth-promoting and tumor-protecting effects of
epithelial nicotinic acetylcholine receptors. Int Immunopharmacol.
29:36–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Brown KC, Lau JK, Dom AM, Witte TR, Luo H,
Crabtree CM, Shah YH, Shiflett BS, Marcelo AJ, Proper NA, et al:
MG624, an α7-nAChR antagonist, inhibits angiogenesis via the
Egr-1/FGF2 pathway. Angiogenesis. 15:99–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Shen J, Xu L, Owonikoko TK, Sun SY, Khuri
FR, Curran WJ and Deng X: NNK promotes migration and invasion of
lung cancer cells through activation of c-Src/PKCι/FAK loop. Cancer
Lett. 318:106–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Iskandar AR, Miao B, Li X, Hu KQ, Liu C
and Wang XD: β-cryptoxanthin reduced lung tumor multiplicity and
inhibited lung cancer cell motility by downregulating nicotinic
acetylcholine receptor α7 signalingg. Cancer Prev Res (Phila).
9:875–886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang C, Yu P, Zhu L, Zhao Q, Lu X and Bo
S: Blockade of α7 nicotinic acetylcholine receptors inhibit
nicotine-induced tumor growth and vimentin expression in non-small
cell lung cancer through MEK/ERK signaling way. Oncol Rep.
38:3309–3318. 2017.PubMed/NCBI
|
|
68
|
Mucchietto V, Fasoli F, Pucci S, Moretti
M, Benfante R, Maroli A, Di Lascio S, Bolchi C, Pallavicini M,
Dowell C, et al: α9- and α7-containing receptors mediate the
pro-proliferative effects of nicotine in the A549 adenocarcinoma
cell line. Br J Pharmacol. Jul 20. 2017, (Epub ahead of print).
PubMed/NCBI
|
|
69
|
Yan Y, Su C1, Hang M, Huang H, Zhao Y,
Shao X and Bu X: Recombinant Newcastle disease virus rL-RVG
enhances the apoptosis and inhibits the migration of A549 lung
adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine
receptors in vitro. Virol J. 14:1902017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Paleari L, Cesario A, Fini M and Russo P:
alpha7-Nicotinic receptor antagonists at the beginning of a
clinical era for NSCLC and Mesothelioma? Drug Discov Today.
14:822–836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Cavallaro U and Christofori G: Molecular
mechanisms of tumor angiogenesis and tumor progression. J
Neurooncol. 50:63–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wu MY, Li CJ, Yiang GT, Cheng YL, Tsai AP,
Hou YT, Ho YC, Hou MF and Chu PY: Molecular regulation of bone
metastasis pathogenesis. Cell Physiol Biochem. 46:1423–1438. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Clark AG and Vignjevic DM: Modes of cancer
cell invasion and the role of the microenvironment. Curr Opin Cell
Biol. 36:13–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Shenker RF, McTyre ER, Ruiz J, Weaver KE,
Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR,
Watabe K, et al: The Effects of smoking status and smoking history
on patients with brain metastases from lung cancer. Cancer Med.
6:944–952. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Warren GW, Sobus S and Gritz ER: The
biological and clinical effects of smoking by patients with cancer
and strategies to implement evidence-based tobacco cessation
support. Lancet Oncol. 15:e568–e580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Gopalakrishna R, Chen ZH and Gundimeda U:
Tobacco smoke tumor promoters, catechol and hydroquinone, induce
oxidative regulation of protein kinase C and influence invasion and
metastasis of lung carcinoma cells. Proc Natl Acad Sci USA.
91:12233–12237. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yoshino I and Maehara Y: Impact of smoking
status on the biological behavior of lung cancer. Surg Today.
37:725–734. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Schuller HM: Neurotransmitter
receptor-mediated signaling pathways as modulators of
carcinogenesis. Prog Exp Tumor Res. 39:45–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
